Shares of Cameco Co. (TSE:CCO – Get Rating) (NYSE:CCJ) have been assigned an average rating of “Buy” from the eleven analysts that are presently covering the company, MarketBeat Ratings reports. Nine research analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have issued ratings on the stock in the last year is C$41.64.
Several research firms have recently weighed in on CCO. Scotiabank increased their price target on Cameco from C$40.00 to C$47.00 in a research note on Wednesday, April 13th. Royal Bank of Canada cut their target price on shares of Cameco from C$50.00 to C$45.00 and set an “outperform” rating for the company in a research report on Friday, May 6th. Canaccord Genuity Group boosted their price target on shares of Cameco from C$34.00 to C$37.00 in a research report on Thursday, February 10th. Eight Capital raised their price objective on shares of Cameco from C$38.00 to C$48.00 and gave the stock a “buy” rating in a report on Thursday, April 21st. Finally, Bank of America boosted their target price on shares of Cameco from C$40.00 to C$46.00 and gave the company a “buy” rating in a report on Tuesday, April 12th.
TSE CCO traded up C$0.48 on Friday, hitting C$30.10. 2,085,391 shares of the stock traded hands, compared to its average volume of 2,015,728. The company has a debt-to-equity ratio of 21.33, a quick ratio of 3.86 and a current ratio of 5.05. The business’s fifty day moving average is C$34.25 and its two-hundred day moving average is C$30.97. Cameco has a 12 month low of C$19.68 and a 12 month high of C$41.05. The firm has a market capitalization of C$11.99 billion and a price-to-earnings ratio of -202.01.
About Cameco (Get Rating)
Cameco Corporation produces and sells uranium. It operates through two segments, Uranium and Fuel Services. The Uranium segment is involved in the exploration for, mining, and milling, as well as purchase and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.
Featured Stories
- MarketBeat: Week in Review 5/16 – 5/20
- 3 Retailers That Defied First Quarter Headwinds
- Rapid7: Could Be Profitable in FY 2022 Despite Bear Market
- Will John Deere’s Earnings Help to Calm the Markets?
- Lowe’s Companies Has Not Bottomed
Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.